Clinical Trial Update: Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of darolutamide with androgen deprivation therapy after radical prostatectomy without extended pelvic lymph node dissec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Darolutamide (darolutamide)

Snippet

Sponsor: Peking University First Hospital | Conditions: Prostate Cancer | Phase 2 | Status: NOT_YET_RECRUITING